Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 1.04 below Bionano Genomics Inc 's average Quick Ratio.

Within Laboratory Analytical Instruments industry 12 other companies have achieved higher Quick Ratio than Bionano Genomics Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1513 to 1940.

Explain Quick Ratio?
How much Cash & cash equivalents BNGO�s has?
What are BNGO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BNGO Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	-58.48 %	-19.62 %	-38.57 %	-30.27 %	-34.96 %
Y / Y Cash & cash equivalent Change	-62.02 %	-15.6 %	166.48 %	38.74 %	44.86 %
Quick Ratio MRQ	1.04	1.16	2.38	1.39	1.13
BNGO's Total Ranking	# 1940	# 1513	# 1490	# 1040	# 1347
Seq. Current Liabilities Change	-52.71 %	-7.47 %	-0.15 %	-4.97 %	-8.44 %
Seq. Cash & cash equivalent Change	-57.76 %	-54.78 %	71.32 %	16.07 %	-6.13 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 13
Healthcare Sector	# 618
Overall Market	# 1940

Quick Ratio Statistics
High	Average	Low
52.72	5.51	0.06
(Mar 31 2021)		(Dec 31 2017)

Financial Statements
Bionano Genomics Inc 's Current Liabilities	$ 10 Millions	Visit BNGO's Balance sheet
Bionano Genomics Inc 's Cash & cash equivalent	$ 10 Millions	Visit BNGO's Balance sheet
Source of BNGO's Sales		Visit BNGO's Sales by Geography

Cumulative Bionano Genomics Inc 's Quick Ratio

BNGO's Quick Ratio for the trailling 12 Months

BNGO Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-36.15 %	-31.78 %	-41.86 %	-27.08 %	-24.13 %
Y / Y Cash & cash equivalent TTM Growth	21.38 %	51.22 %	24.27 %	-44.55 %	-57.8 %
Quick Ratio TTM	1.57	1.52	1.48	0.98	0.83
Total Ranking TTM	# 4027	# 3097	# 3038	# 2498	# 3116
Seq. Current Liabilities TTM Growth	-15.48 %	-5.37 %	-12.99 %	-8.25 %	-9.71 %
Seq. Cash & cash equivalent TTM Growth	-12.29 %	-3.19 %	31.27 %	8.88 %	9.28 %

Quick ratio ranking by company, industry and sector >> Back to BNGO Financial Strength Comparisons >> Go to Compare BNGO Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Bionano Genomics Inc 's average Cash & cash equivalent, this led to increase in in Bionano Genomics Inc 's Quick Ratio to 1.57, Quick Ratio remained below BNGO average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Bionano Genomics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3097 to 4027.

Explain Quick Ratio?
How much Cash & cash equivalents BNGO�s has?
What are BNGO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 901
Within the Market	# 4027

trailing twelve months Quick Ratio Statistics
High	Average	Low
19.62	2.85	0.37
(Sep 30 2021)		(Jun 30 2023)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Cytek Biosciences Inc	2.83	$ 262.004 Millions	$ 92.698 Millions
Quanterix Corporation	1.86	$ 93.529 Millions	$ 50.373 Millions
Nautilus Biotechnology Inc	1.52	$ 13.166 Millions	$ 8.639 Millions
Rapid Micro Biosystems Inc	1.13	$ 20.500 Millions	$ 18.150 Millions
Bionano Genomics Inc	1.04	$ 10.420 Millions	$ 10.039 Millions
Bio rad Laboratories Inc	0.92	$ 886.900 Millions	$ 961.300 Millions
Precipio inc	0.83	$ 3.075 Millions	$ 3.701 Millions
Lifeloc Technologies Inc	0.83	$ 0.908 Millions	$ 1.099 Millions
Agilent Technologies inc	0.77	$ 1,758.000 Millions	$ 2,289.000 Millions
Revvity Inc	0.67	$ 1,022.943 Millions	$ 1,516.157 Millions
Harvard Bioscience Inc	0.26	$ 6.503 Millions	$ 24.793 Millions
Waters Corporation	0.22	$ 539.000 Millions	$ 2,399.000 Millions
Kewaunee Scientific Corporation	0.22	$ 10.261 Millions	$ 47.235 Millions

Date modified: 2026-09-08T16:48:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.